Today we’re happy and proud here at DiabetesMine. By all accounts, the DiabetesMine Design Challenge we’ve hosted here for the past three years has been a roaring success. We inspired creative thinkers from all over the country and all over the world to design and showcase more than 300 innovative concepts. We helped place some of these talented young thinkers in key positions in the industry. And we managed – on a patient blog and…Read more »
This weekend, at Stanford Campus in Palo Alto, CA, I’m proud to say we hosted a historical gathering of different stakeholders around innovation in diabetes… The first-ever DiabetesMine Innovation Summit gathered in one room about 60 designers, web visionaries, Pharma Marketing and R&D folks, experts from venture capital investment, innovation and regulatory experts, and passionate patient advocates.
The aim was to kick off a new era of collaboration among these various stakeholders, to begin revolutionizing…Read more »
Are you a teen with diabetes with some strong opinions about the best and worst designed tools currently on the market for managing your illness? Tell us what you think!
Note that you don’t have to be a teen, but we are encouraging input from that age group, since adults with diabetes will be well-represented next month at an exciting “meeting of the minds” we are hosting in two weeks at Stanford University: The DiabetesMine™…
If there’s one thing we here at the ‘Mine can get behind, it’s innovation in diabetes technology. After all, Amy did launch the DiabetesMine Design Challenge four years ago after her popular Open Letter to Steve Jobs post was published. So that’s why we were excited to see that this month’s DSMA Blog Carnival challenge is all about diabetes technology, especially after spending weeks looking at all the wonderful submissions to this year’s contest. We…Read more »
The Pancreum closed loop (automated insulin + CGM + glucagon) system that won a Grand Prize in the DiabetesMine Design Challenge this year may look like a pipe dream, but designer Gil DePaula assures us it is “visionary but real.”
Have a look at the video, below, and also Gil’s company website.
“The glucagon part is definitely a futuristic concept — because there’s no predicate device for glucagon delivery with the FDA, so that’s a…Read more »